Cyclerion Therapeutics Inc (CYCN) Technical Analysis
$1.52▲0.66%
Market is closed - opens 7 PM, 23 Mar 2026
Insights
- Cyclerion Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Cyclerion Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Cyclerion Therapeutics stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Cyclerion Therapeutics stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 67.27 | Sell |
Stochastic | 92.15, 71.57 | Neutral |
Ultimate Oscillator | 70.0 | Sell |
Stochastic Relative Strength Index | 86.29, 81.31 | Neutral |
Moving Average Convergence Divergence | 0.05, 0.03 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.48 | Buy |
20 | 1.41 | Buy |
50 | 1.39 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.48 | Buy |
20 | 1.43 | Buy |
50 | 1.42 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.48 | Neutral |
20 | 1.41 | Buy |
50 | 1.53 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.53 | Buy |
20 | 1.49 | Buy |
50 | 1.35 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.55 | Buy |
20 | 1.54 | Buy |
50 | 1.43 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 1.68 |
Resistance L2 | 1.61 |
Resistance L1 | 1.56 |
Pivot Point | 1.49 |
Support L1 | 1.44 |
Support L2 | 1.37 |
Support L3 | 1.32 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.